FDA Issues Discussion Paper on Generative AI-Enabled Medical Devices

The FDA has released a discussion paper seeking public input on frameworks for risk assessment, premarket evaluation, and postmarket monitoring of generative AI-enabled medical devices. This regulatory guidance aims to establish standardized approaches for evaluating AI technologies in healthcare.